Related references
Note: Only part of the references are listed.Mitotic checkpoint defects: en route to cancer and drug resistance
Sinjini Sarkar et al.
CHROMOSOME RESEARCH (2021)
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Yael Cohen-Sharir et al.
NATURE (2021)
The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
Stijn Moens et al.
SCIENTIFIC REPORTS (2021)
Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer
Naheed Arfin Borah et al.
MOLECULES (2021)
Structural Chromosome Instability: Types, Origins, Consequences, and Therapeutic Opportunities
Sebastian Omar Siri et al.
CANCERS (2021)
Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
Wenxin Zeng et al.
CANCER CELL INTERNATIONAL (2020)
Too MAD or not MAD enough: The duplicitous role of the spindle assembly checkpoint protein MAD2 in cancer
Mark Bates et al.
CANCER LETTERS (2020)
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
Laura M Spring et al.
LANCET (2020)
Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases
N. S. Persky et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
CDK7 inhibitors as anticancer drugs
Georgina P. Sava et al.
CANCER AND METASTASIS REVIEWS (2020)
Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
Monica Alvarez-Fernandez et al.
CANCER CELL (2020)
CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells
Rebecca F. Rogers et al.
CANCER RESEARCH (2020)
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti et al.
CELL (2020)
Cyclin A triggers Mitosis either via the Greatwall kinase pathway or Cyclin B
Nadia Hegarat et al.
EMBO JOURNAL (2020)
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase
Volker K. Schulze et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
Theresa E. Leon et al.
CANCER DISCOVERY (2020)
Restriction point regulation at the crossroads between quiescence and cell proliferation
Betheney R. Pennycook et al.
FEBS LETTERS (2020)
DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons
Therese Wilhelm et al.
GENES (2020)
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells
M. Caillot et al.
ONCOGENESIS (2020)
The Mechanics of Mitotic Cell Rounding
Anna Taubenberger et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Senescence as a therapeutically relevant response to CDK4/6 inhibitors
Verena Wagner et al.
ONCOGENE (2020)
Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma
Sonia Simon Serrano et al.
SCIENTIFIC REPORTS (2020)
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Andrea Ghelli Luserna di Rora et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Integrating Old and New Paradigms of G1/S Control
Seth M. Rubin et al.
MOLECULAR CELL (2020)
Way Great Mitotic Inhibitors Make Poor Cancer Drugs
Victoria C. Yan et al.
TRENDS IN CANCER (2020)
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Rui-Xue Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A Code of Mono-phosphorylation Modulates the Function of RB
Ioannis Sanidas et al.
MOLECULAR CELL (2019)
The multiple mechanisms that regulate p53 activity and cell fate
Antonina Hafner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer
Ping Lu et al.
ONCOGENE (2019)
Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB
Amy E. Schade et al.
ONCOGENE (2019)
Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma
Xinyi Cao et al.
THYROID (2019)
CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer
Shanshan Zhong et al.
ONCOTARGETS AND THERAPY (2019)
Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix
Benjamin R. Topacio et al.
MOLECULAR CELL (2019)
The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells In Vitro and In Vivo
Yu Zhang et al.
CLINICAL CANCER RESEARCH (2019)
DNA double-strand break repair-pathway choice in somatic mammalian cells
Ralph Scully et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Orchestration of the spindle assembly checkpoint by CDK1-cyclin B1
Daniel Hayward et al.
FEBS LETTERS (2019)
Getting out of mitosis: spatial and temporal control of mitotic exit and cytokinesis by PP1 and PP2A
James Holder et al.
FEBS LETTERS (2019)
Force-generating mechanisms of anaphase in human cells
Kruno Vukusic et al.
JOURNAL OF CELL SCIENCE (2019)
Transient Hysteresis in CDK4/6 Activity Underlies Passage of the Restriction Point in G1
Mingyu Chung et al.
MOLECULAR CELL (2019)
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)
Concepcion Sanchez-Martinez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Triggering mitosis
Adrijana Crncec et al.
FEBS LETTERS (2019)
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang et al.
NATURE (2019)
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo
Gerhard Siemeister et al.
CLINICAL CANCER RESEARCH (2019)
Anti-mitotic therapies in cancer
Julia Tischer et al.
JOURNAL OF CELL BIOLOGY (2019)
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
Keelan Z. Guiley et al.
SCIENCE (2019)
Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division
Ana Rita R. Maia et al.
BRITISH JOURNAL OF CANCER (2018)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor et al.
CANCER CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Kinetochore assembly and disassembly during mitotic entry and exit
Masatoshi Hara et al.
CURRENT OPINION IN CELL BIOLOGY (2018)
Structural biology of the separase-securin complex with crucial roles in chromosome segregation
Shukun Luo et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma
Philip Eliades et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy et al.
LANCET ONCOLOGY (2018)
CENP-E as a target for cancer therapy: Where are we now?
Amr Ahmed El-Arabey et al.
LIFE SCIENCES (2018)
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
Hetal Patel et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Targeting the replication stress response in cancer
Josep V. Forment et al.
PHARMACOLOGY & THERAPEUTICS (2018)
ATR/CHK1 inhibitors and cancer therapy
Zhaojun Qiu et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
Panagiotis Kotsantis et al.
CANCER DISCOVERY (2018)
Inhibition of cyclin-dependent kinase 7 suppresses human hepatocellular carcinoma by inducing apoptosis
Liqiang Zhong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
EMI1 switches from being a substrate to an inhibitor of APC/CCDH1 to start the cell cycle
Steven D. Cappell et al.
NATURE (2018)
Aurora-PLK1 cascades as key signaling modules in the regulation of mitosis
Vladimir Joukov et al.
SCIENCE SIGNALING (2018)
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti et al.
SCIENCE (2018)
Mps1/TTK: a novel target and biomarker for cancer
Yuan Xie et al.
JOURNAL OF DRUG TARGETING (2017)
The Role of Aneuploidy in Cancer Evolution
Laurent Sansregret et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Consequences of mitotic slippage for antimicrotubule drug therapy
Bing Cheng et al.
ENDOCRINE-RELATED CANCER (2017)
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
Ankit C. Borisa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
The impact of replication stress on replication dynamics and DNA damage in vertebrate cells
Herve Techer et al.
NATURE REVIEWS GENETICS (2017)
Anti-mitotic agents: Are they emerging molecules for cancer treatment?
Larissa Siqueira Penna et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Inhibitors of cyclin-dependent kinases as cancer therapeutics
Steven R. Whittaker et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Ccc20: At the Crossroads between Chromosome Segregation and Mitotic Exit
Maria Kapanidou et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Quantitative Cell Cycle Analysis Based on an Endogenous All-in-One Reporter for Cell Tracking and Classification
Thomas Zerjatke et al.
CELL REPORTS (2017)
The Role of the Transcriptional Response to DNA Replication Stress
Anna E. Herlihy et al.
GENES (2017)
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
S. A. Greenall et al.
ONCOGENESIS (2017)
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer
Maura N. Dickler et al.
CLINICAL CANCER RESEARCH (2017)
Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel
Patricia M. A. Silva et al.
CANCER LETTERS (2017)
Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression
Laura C. Funk et al.
DEVELOPMENTAL CELL (2016)
Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy
Stephanie M. Myers et al.
FUTURE MEDICINAL CHEMISTRY (2016)
High rates of chromosome missegregation suppress tumor progression but do not inhibit tumor initiation
Lauren M. Zasadil et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity
Antje M. Wengner et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Rosie Elizabeth Ann Gutteridge et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Cryo-EM of Mitotic Checkpoint Complex-Bound APC/C Reveals Reciprocal and Conformational Regulation of Ubiquitin Ligation
Masaya Yamaguchi et al.
MOLECULAR CELL (2016)
Molecular basis of APC/C regulation by the spindle assembly checkpoint
Claudio Alfieri et al.
NATURE (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
MPS1 kinase as a potential therapeutic target in medulloblastoma
Irina Alimova et al.
ONCOLOGY REPORTS (2016)
Thresholds and ultrasensitivity from negative cooperativity
S. H. Ha et al.
SCIENCE (2016)
Targeting WEE1 Kinase in Cancer
Christopher J. Matheson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth
Konstantina Rowald et al.
CELL REPORTS (2016)
Sustained E2F-Dependent Transcription Is a Key Mechanism to Prevent Replication-Stress-Induced DNA Damage
Cosetta Bertoli et al.
CELL REPORTS (2016)
The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
Jiandong Chen
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
A Dynamical Framework for the All-or-None G1/S Transition
Alexis R. Barr et al.
CELL SYSTEMS (2016)
Curing Metastatic Breast Cancer
George W. Sledge
JOURNAL OF ONCOLOGY PRACTICE (2016)
The mitotic checkpoint complex (MCC): looking back and forth after 15 years
Song-Tao Liu et al.
AIMS MOLECULAR SCIENCE (2016)
DNA Replication Stress as a Hallmark of Cancer
Morgane Macheret et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
The Molecular Biology of Spindle Assembly Checkpoint Signaling Dynamics
Andrea Musacchio
CURRENT BIOLOGY (2015)
DNA replication origin activation in space and time
Michalis Fragkos et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Targeting Cdc20 as a novel cancer therapeutic strategy
Lixia Wang et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors
Marion Peyressatre et al.
CANCERS (2015)
Therapeutic opportunities within the DNA damage response
Laurence H. Pearl et al.
NATURE REVIEWS CANCER (2015)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
Replication stress and cancer: It takes two to tango
Emilio Lecona et al.
EXPERIMENTAL CELL RESEARCH (2014)
Roles of Chk1 in cell biology and cancer therapy
Youwei Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
Lawrence M. Gelbert et al.
INVESTIGATIONAL NEW DRUGS (2014)
Causes and consequences of replication stress
Michelle K. Zeman et al.
NATURE CELL BIOLOGY (2014)
Signaling through cyclin D-dependent kinases
Y. J. Choi et al.
ONCOGENE (2014)
Separate to operate: control of centrosome positioning and separation
Fikret G. Agircan et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
Lauren M. Zasadil et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
DNA-Damage Response during Mitosis Induces Whole-Chromosome Missegregation
Samuel F. Bakhoum et al.
CANCER DISCOVERY (2014)
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
Anil M. Narasimha et al.
ELIFE (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
JulieAnn Rader et al.
CLINICAL CANCER RESEARCH (2013)
Start and the restriction point
Amy Johnson et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template
Kai J. Neelsen et al.
GENES & DEVELOPMENT (2013)
Replication stress links structural and numerical cancer chromosomal instability
Rebecca A. Burrell et al.
NATURE (2013)
Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore
Emily A. Foley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Control of cell cycle transcription during G1 and S phases
Cosetta Bertoli et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Genetic instability: tipping the balance
A. Janssen et al.
ONCOGENE (2013)
Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress
R. M. Jones et al.
ONCOGENE (2013)
Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors
Alain D. Silk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ATR Activates the S-M Checkpoint during Unperturbed Growth to Ensure Sufficient Replication Prior to Mitotic Onset
John Kenneth Eykelenboom et al.
CELL REPORTS (2013)
Cytokinesis in Animal Cells
Rebecca A. Green et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 28 (2012)
Spatial Positive Feedback at the Onset of Mitosis
Silvia D. M. Santos et al.
CELL (2012)
Linking abnormal mitosis to the acquisition of DNA damage
Neil J. Ganem et al.
JOURNAL OF CELL BIOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons
Sean D. Ryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
Rebecca Roylance et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Paradoxical Relationship between Chromosomal Instability and Survival Outcome in Cancer
Nicolai J. Birkbak et al.
CANCER RESEARCH (2011)
Chromosomal Instability Confers Intrinsic Multidrug Resistance
Alvin J. X. Lee et al.
CANCER RESEARCH (2011)
Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development
Assaf C. Bester et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
Luis I. Toledo et al.
MOLECULAR ONCOLOGY (2011)
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
Matilde Murga et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
Luis I. Toledo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Chromosome Segregation Errors as a Cause of DNA Damage and Structural Chromosome Aberrations
Aniek Janssen et al.
SCIENCE (2011)
Quantitative Phosphoproteomics Identifies Substrates and Functional Modules of Aurora and Polo-Like Kinase Activities in Mitotic Cells
Arminja N. Kettenbach et al.
SCIENCE SIGNALING (2011)
Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
Olivier Gavet et al.
DEVELOPMENTAL CELL (2010)
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
Sarah L. Thompson et al.
JOURNAL OF CELL BIOLOGY (2010)
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function
Nicholas Kwiatkowski et al.
NATURE CHEMICAL BIOLOGY (2010)
Chk1 promotes replication fork progression by controlling replication initiation
Eva Petermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ATM-Dependent and -Independent Dynamics of the Nuclear Phosphoproteome After DNA Damage
Ariel Bensimon et al.
SCIENCE SIGNALING (2010)
Pharmacologic Abrogation of the Mitotic Spindle Checkpoint by an Indolocarbazole Discovered by Cellular Screening Efficiently Kills Cancer Cells
Ailine Stolz et al.
CANCER RESEARCH (2009)
TopBP1 and DNA polymerase alpha-mediated recruitment of the 9-1-1 complex to stalled replication forks Implications for a replication restart-based mechanism for ATR checkpoint activation
Shan Yan et al.
CELL CYCLE (2009)
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
H. Christian Reinhardt et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
Hiroshi Hirai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Cyclin A-Cdk1 regulates the origin firing program in mammalian cells
Yuko Katsuno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chromosomal instability determines taxane response
Charles Swanton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Sensing Chromosome Bi-Orientation by Spatial Separation of Aurora B Kinase from Kinetochore Substrates
Dan Liu et al.
SCIENCE (2009)
Tumor Suppressive Functions of p53
Jack T. Zilfou et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen et al.
NATURE REVIEWS CANCER (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates
Justin D. Blethrow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A quantitative atlas of mitotic phosphorylation
Noah Dephoure et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ATR-dependent pathways control hEXO1 stability in response to stalled forks
Mahmoud El-Shemerly et al.
NUCLEIC ACIDS RESEARCH (2008)
Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris
T. Boveri
JOURNAL OF CELL SCIENCE (2007)
DNA damage signalling guards against activated oncogenes and tumour progression
J. Bartek et al.
ONCOGENE (2007)
The mammalian DNA replication elongation checkpoint - Implication of Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analyses
Chiara Conti et al.
CELL CYCLE (2007)
Non-transcriptional control of DNA replication by c-Myc
David Dominguez-Sola et al.
NATURE (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
A census of mitotic cancer genes:: new insights into tumor cell biology and cancer therapy
Ignacio Perez de Castro et al.
CARCINOGENESIS (2007)
Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells
Emily E. Arias et al.
GENES & DEVELOPMENT (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision
Iain F. Davidson et al.
MOLECULAR CELL (2006)
Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint
Daniela A. Brito et al.
CURRENT BIOLOGY (2006)
ATM and ATR promote Mre11 dependent restart of collapsed replication forks and prevent accumulation of DNA breaks
Kristina Trenz et al.
EMBO JOURNAL (2006)
Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase
E Petermann et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability
BB Yuan et al.
CLINICAL CANCER RESEARCH (2006)
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
T Fujiwara et al.
NATURE (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
E Hernando et al.
NATURE (2004)
The DNA damage response: sensing and signaling
CH McGowan et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint
GJPL Kops et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects
G Zachos et al.
EMBO JOURNAL (2003)
ATR regulates fragile site stability
AM Casper et al.
CELL (2002)
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing
C Feijoo et al.
JOURNAL OF CELL BIOLOGY (2001)
Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2
V Sudakin et al.
JOURNAL OF CELL BIOLOGY (2001)
Cell cycle checkpoint signaling through the ATM and ATR kinases
RT Abraham
GENES & DEVELOPMENT (2001)
The DNA replication checkpoint response stabilizes stalled replication forks
M Lopes et al.
NATURE (2001)
Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint
JA Tercero et al.
NATURE (2001)
Cyclin a is destroyed in prometaphase and can delay chromosome alignment and anaphase
N den Elzen et al.
JOURNAL OF CELL BIOLOGY (2001)
Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin a starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint
S Geley et al.
JOURNAL OF CELL BIOLOGY (2001)
Positive regulation of Wee1 by Chk1 and 14-3-3 proteins
J Lee et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Temporally coordinated assembly and disassembly of replication factories in the absence of DNA synthesis
DS Dimitrova et al.
NATURE CELL BIOLOGY (2000)
DNA damage-induced activation of p53 by the checkpoint kinase Chk2
A Hirao et al.
SCIENCE (2000)
Share Paper
